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Objective: To identify and evaluate the correlation between leukocyte count in maternal blood and the risk of
developing fetal inflammatory response syndrome (FIRS).
Patients and methods: The study involved 158 infants born at 2234 weeks of gestation and their mothers.
Umbilical cord blood cytokines were evaluated in immunoassay tests and maternal blood was tested for the
leukocyte formula.
Results: The period of gestation was significantly shorter in the FIRS group compared to the control
group (29.593.1 vs. 32.292.4 weeks, pB0.001). Gestational age was 530 weeks for 53.8% of the newborns
in the FIRS group and 15.8% of the newborns in the control group (pB0.001). The number of leuko-
cytes in maternal blood before and during labor was significantly higher in the FIRS group than in the
control group (p0.034 and 0.004, respectively). The study determined the correlation between the total
leukocyte count in maternal blood and IL-6 concentration during labor (p0.05) and tumor necrosis
factor (TNF-a) concentration in umbilical cord blood before and during labor (p0.02 and 0.007,
respectively).
Conclusion: Leukocytosis in the FIRS group was significantly higher than in the control group before and
during labor. According to our data, one of the possible indicators of intrauterine infection could be the
number of leukocytes in maternal blood.
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reterm delivery is the major cause of perinatal
mortality and morbidity in Lithuania, where the
rate of preterm deliveries remains approximately
56% of all deliveries (1). The rate of mortality is 2030
times higher in preterm infants than those born at term
and accounts for 80% of total neonatal deaths and 40%
of infant deaths (1, 2).
The most frequent reason for preterm delivery is in-
trauterine infection (about 40% of all preterm deliveries).
This rate is inversely proportional to gestational age
(35). Intrauterine infection may cause fetal infection
and inflammation that could lead to the heaviest inflam-
matory response in the fetus, defined by fetal inflamma-
tory response syndrome (FIRS). FIRS is characterized by
increase of IL-6 level in fetal blood plasma (]11 pg/ml)
and the presence of umbilical cord inflammation (funisi-
tis) (6, 7). FIRS may cause heavy damage in the fetus
and newborns, as well as respiratory distress syndrome,
neonatal sepsis, pneumonia, bronchial-pulmonary dys-
plasia, necrotizing enterocolitis, intraventricular hemor-
rhage, and periventricular leukomalacia (6). Moreover,
fetal exposure to infection may cause fetal death and
neonatal sepsis (3, 811).
Intrauterine infection is often chronic and non-
symptomatic, so it is very important to find markers to
help identify pregnant woman at high risk for intrau-
terine infection, prognosticate the possibility of FIRS
development, and prevent the development of threatening
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complications. Therefore, it is important to determine
critical values of inflammatory markers for identification
of intrauterine infection that could lead to premature
birth.
The aim of this study was to identify and evaluate the
correlation between leukocyte concentration in maternal
blood and the risk of developing FIRS.
Patients and methods
This casecontrol study was performed in Vilnius City
Clinical Hospital during 20072009. In this third-level
hospital, there are about 3,500 births every year (i.e.
about 12% of all newborns in Lithuania). About 1011%
of all deliveries are premature.
The study involved 158 infants born at 2234 weeks
of gestation and their mothers. The eligibility criteria
were as follows: 1) mother’s age18 years; 2) gestation
of 2234 weeks and 6 days; 3) properly attached placenta;
4) no diabetes, chronic cardiovascular and respiratory
system diseases, severe anemia (HbB80.00 g/L) or auto-
immune or oncological diseases in the mother. The
exclusion criterion were the following: 1) stillbirth; 2)
alcoholism and/or drug addiction of the woman; 3)
malformations in newborn; 4) hemolytic newborn dis-
ease; 5) umbilical cord artery blood pHB7.00; 6) birth
trauma in the newborn; 7) mother’s refusal to participate
in the study.
All newborns and their mothers were investigated
according to the same scheme: 1) umbilical cord blood
cytokines IL-6 and tumor necrosis factor (TNF-a) were
evaluated in each newborn; 2) depending on the con-
centration of umbilical cord blood’s IL-6, the newborns
were assigned to FIRS (IL-6]11 pg/ml) or control (IL-
6B11 pg/ml) group; 3) each mother was tested for total
leukocyte count and leukocyte formula of the blood
before, during, and after labor; 4) the correlation between
the number of leukocytes in maternal blood and con-
centration of various cytokines in umbilical cord blood
was evaluated; 5) the correlation between leukocytosis
in maternal blood before, during, and after labor and
the development of FIRS was evaluated. In addition, the
culture of cervical secretions, C-reactive protein (CRP) in
maternal blood, histological placenta study, and bacte-
riologic newborn blood test were performed.
Immunological studies of cord blood cytokines were
performed at the State Research Institute Center for
Innovative Medicine. After birth, the umbilical blood
cord vein was punctured and 5 ml of blood was taken
into a vacuum tube. Within 1 h, the blood sample was
centrifuged for 14 min at 1,500 rpm/min and plasma
was immediately frozen at 808C until assayed. IL-6 and
TNF-a levels in umbilical cord blood plasma were
measured with commercially available enzyme-linked im-
munosorbent assay (ELISA) kits (Bender MedSystems,
Austria) according to the manufacturer’s protocols.
A special program calculated the amount of cytokines
for ELISA (Gen5 Microplate Data Collection & Analysis
Software; BioTek Instruments, USA).
Statistics were performed using the SPSS statistics soft-
ware version 15.0. Data are presented as mean9SD,
median, minimum, and maximum. Quantitative variables
of two independent groups were compared by the para-
metric Student t-test and non-parametric MannWhitney
test. For assessing the correlation between results, the
Spearman test was used. pB0.05 were considered sig-
nificant. The specificity and sensitivity of testing were
assessed by analyzing receiver operator characteristic
curves (ROC).
The study was performed with permission No. 14




The average age of the mothers in the FIRS group was
27.396.5 years and in the control group 28.395.2 years,
but the difference was not significant (p0.05). The level
of CRP in maternal blood before, during, and after labor
was significantly higher in the FIRS group compared to
the control group (pB0.001). The study determined the
correlation between CRP in maternal blood and IL-6
concentration during all prenatal periods (pB0.001). The
culture of the cervical secretions was done during the
perinatal period for 42% of the mothers. The occurrence
of a positive culture in the FIRS group was not sig-
nificantly different from the control group (p0.05). In
the histological placenta study, inflammatory changes
in placenta were detected in 40.3% of the cases studied.
The frequency of histological chorioamnionitis without
funisitis and deciduitis did not differ between the two
groups (p0.05). Histological chorioamnionitis with funi-
sitis was found in 51% of placentas in the FIRS group,
while the control group demonstrated such changes
in only 1% of placentas (pB0.001). No pathological
changes were detected in 10% of placentas in the FIRS
group.
The sex of newborns was distributed almost equally
between boys and girls: 49.4% of newborns were boys
and 50.6% were girls (p=0.82). The average period of
gestation was 31.392.9 weeks, and it was significantly
(pB0.001) shorter in the FIRS group (29.593.1 weeks)
than in the control group (32.292.4 weeks). Gestational
age was530 weeks in 53.8% of the newborns in the FIRS
group and 15.8% of the newborns in the control group
(pB0.001). The mean weight of the FIRS group new-
borns was 1,424.79564.0 g and of the control group
2,006.39554.1 g (pB0.001). The average umbilical cord
artery blood pH in newborns was 7.390.1; no difference
between groups was observed (p0.05). Bacteriologic
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blood test was performed on 139 newborns. Positive
blood cultures were found in one newborn from the FIRS
group and one from the control group (p=1.0). Lysteria
monocytogenes was cultured in the blood sample of the
newborn from the FIRS group, and Klebsiella pneumonia
from the blood sample of one from the control group.
The total leukocyte count and leukocyte formula in
maternal blood
In this study we compared the leukocyte count in
maternal blood sample before, during, and after labor
(Table 1).
While examining maternal blood samples during dif-
ferent periods, elevated levels of leukocytes before (13.209
4.80109/L) and during labor (14.0494.80109/L) were
detected in the FIRS group (Table 1). Total leukocyte
count of these FIRS stages was significantly higher than
in the control group (p=0.034 and 0.004, respectively).
The critical values of leukocytes in maternal blood for
predicting the development of FIRS are presented in
Figs. 1 and 2 and in Table 2. No significant difference was
detected between other blood cell fractions  erythrocytes
and platelets  between the groups (p0.05).
The concentration of cytokines in umbilical
cord blood
Each newborn was tested for umbilical cord blood cyto-
kines IL-6 and TNF-a. The study determined correlation
between the total leukocyte count in maternal blood and
IL-6 concentration in umbilical cord blood during labor
(p=0.05) (Table 3).
Also, a significant difference was detected between the
leukocytes count in maternal blood and TNF-a concen-
tration in umbilical cord blood before and during labor
(p=0.02 and 0.007, respectively) (Table 3).
Discussion
Leukocytosis is characterized by an elevated number of
white cells in the blood (11.00109/L). Leukocytosis
may be physiological, caused by fasting, pregnancy,
strong emotions or high stress, or pathological due to
the bone marrow’s response to inflammation or infection.
Pregnancy causes a great variety of changes in preg-
nant woman organism and is mostly associated with
suppression of humoral and cellular immune functions in
order to tolerate the ‘foreign’ semiallogeneic fetal graft
(12). One of the most important mechanisms, which
continue throughout pregnancy, involves the suppression
of IL-2, IFN-g, TNF-b, polymorphonuclear leukocyte
chemotaxis, and adherence functions (12).
On the contrary, not all aspects of immunological func-
tion are depressed. For example, there is up-regulation of
Th2 cells to increase the secretion of IL-4, IL-6, and IL-
13 (12). In cervical mucus, peak levels of immunoglobu-
lins A and G are significantly higher in pregnant women
compared with normally menstruating women (13). The
amount of IL-1b found in cervical mucus during preg-
nancy is approximately 10-fold greater than in the non-
pregnant state (12, 14).
According to different studies, the leukocyte count
during normal pregnancy varies from 5.00 to 12.00
109/L (12). Moreover, during labor and the early post-
natal period it may become considerably elevated, up to
25.00109/L or even more (averages 14.0016.00109/
L) (12). It is noted that the percentages of granulocytes
and CD8 T lymphocytes are significantly increased dur-
ing the third trimester. At the same time, the percentages
of CD4 T lymphocytes and monocytes decrease (12).
So it is often said that the leukocyte count in maternal
blood during the perinatal period is not a reliable marker
for diagnosing intrauterine infection as the cause of
premature delivery (1).
In this study, we found that the average of the leuko-
cyte count in maternal blood was higher in both groups
than the normal range (4.5010.00109/L). In the FIRS
group, leukocytosis was significantly higher before and
during labor than in the control group (p=0.034 and
0.004, respectively). Also, we identified a correlation
(p=0.05) between leukocytes count in maternal blood
during labor and IL-6 in umbilical cord blood. Moreover,
we determined the association between leukocytosis in
mothers’ blood before and during labor and TNF-a in
umbilical cord blood (p=0.02 and 0.007, respectively).
IL-6 and TNF-a are very important in premature
delivery. IL-6 is an acute inflammatory response phase
marker that induces the secretion of various acute phase










Median 12.74 11.43 0.034
[min  max] [6.5325.52] [3.6225.46]
during labor (109/L)
Mean9SD 14.0494.80 11.393.74
Median 13.31 11.61 0.004
[min  max] [6.5325.34] [5.7326.30]
after labor (109/L)
Mean9SD 12.9394.64 12.1293.73
Median 12.23 11.65 0.565
[min  max] [6.7324.88] [5.7325.46]
$MannWhitney test; FIRS, fetal inflammatory response syndrome;
SD, standard deviation.
Significant values are set in bold.
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Fig. 1. ROC curves analysis for determining the critical values of leukocytes in maternal blood before labor.
Fig. 2. ROC curves analysis for determining the critical values of leukocytes in maternal blood during labor.
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proteins (e.g. CRP), and increases in the mother’s blood
and amniotic fluid, if premature delivery is caused by
intrauterine infection (2, 15, 16). Moreover, elevation of
IL-6 levels is part of the definition of FIRS (6, 7).
Another important factor is TNF-a, which stimulates
prostaglandin synthesis in the chorioamniotic mem-
branes, decidual plate and uterus muscles. In the pre-
sence of TNF-a, metalloproteases and other bioactive
substances are released. The prostaglandins stimulate
uterine contractions while the metalloproteases have a
strong effect on the chorioamniotic membranes, leading
to their rupture (2, 1721).
Although the cultures from the cervix were taken from
only 42% of the mothers, positive results were found in
up to 40% of the cultures. The number of positive cultures
in the FIRS and the control groups were similar. This
is because microbial invasion of amniotic fluid is often
chronic and clinically silent in the mid-trimester of preg-
nancy, culminating in premature labor (22, 23). Different
studies point out that an increased level of cytokines in
a woman’s blood and histological chorioamnionitis are
associated with the woman’s inflammatory reaction, while
an increased concentration of inflammatory cytokines in
fetal blood and funisitis show that the fetus is involved in
this reaction, i.e. processes described as FIRS take place
(7, 9, 24). According to our data, histological inflamma-
tory changes in the placenta were detected in 40% of the
cases studied (25). Similar results have been demonstra-
ted by others as well (24). The frequency of histological
chorioamnionitis and deciduitis, which would confirm an
inflammatory reaction initiated by the mother’s body, did
not differ between the groups. Histological chorioamnio-
nitis with funisitis was found in 51% of placentas in the
FIRS group but in only 1% of placentas in the control
group, which confirms close associations between FIRS
and funisitis.
In our study, bacteriologically confirmed neonatal
sepsis was diagnosed in two newborns (1.3%). One was
in the FIRS group and the other in the control group,
so no correlation was found between FIRS and early
neonate sepsis. According to the published scientific
data, the frequency of early neonate sepsis in newborns
younger than 30 weeks of gestation accounts for about
7% (26). Alabama preterm delivery data suggest that
Ureaplasma urealyticum and Mycoplasma hominis were
detected in umbilical cord blood of 23% of very early
preterm neonates (27), but in Lithuania these intrauterine
infectious agents are rarely detected in newborns’ blood.
Conclusion
Leukocytosis in the FIRS group was significantly higher
than in the control group before and during labor.
According to our data, one of the possible indicators of
intrauterine infection could be the number of leukocytes
in maternal blood.
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